Nothing is more important to Promius Pharma than protecting the private information of visitors to our site. Below you’ll find information about our commitment to ensuring the privacy of your personally identifiable information (such as your full name, address, email address, telephone number, and/or other identifying information) and preserving the integrity of the medium. Please read the following carefully. If you have any questions or concerns, please send us an email to email@example.com.
Promius Pharma will never willfully disclose any personally identifiable information about our online audience to any third party without first receiving the user’s permission. We do not collect personally identifiable information from our visitors other than what is supplied to us on a voluntary basis.
Visitors to the Trianex® Ointment website may voluntarily supply certain personally identifiable information in connection with (i) subscription registration for sites or services that require subscription (such as email newsletters) and (ii) requests for membership information. In addition, personally identifiable information is voluntarily provided in connection with certain content submissions, community postings (ie, forums or bulletin boards), comments and suggestions, or voting.
Promius Pharma, its affiliates, and service providers may use such information only for conducting the activities stated above, for internal marketing and promotional purposes, or, on occasion, when mailing lists are made available to other organizations. (The occasional provision of mailing lists to such organizations is the only case where such information would be provided to third parties.) The extent of such use is always explained at the time a site visitor provides such information and permission is granted.
INDICATION AND IMPORTANT SAFETY INFORMATION
Trianex® 0.05% (Triamcinolone Acetonide Ointment, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The most common adverse events with Trianex Ointment include burning, itching, irritation, dryness, and folliculitis. Trianex Ointment is contraindicated in patients who are hypersensitive to any of the ingredients of this product. As with all topical corticosteroids, systemic absorption can produce reversible HPA-axis suppression.
Please See Full Prescribing Information.
Trianex is a registered trademark of CMP Pharma, Inc. ©2015 Promius Pharma, LLC. All rights reserved.